United States HRES 928: Affirming support for most-favored-Nation drug pricing for United States patients.

Status: Submitted in House (as of 2025-12-04)

State: United States · Session: 119 · Bill: HRES 928

Sponsors: Debbie Dingell, Elijah Crane

View United States HRES 928 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.